Compare · BFLY vs NNOX
BFLY vs NNOX
Side-by-side comparison of Butterfly Network Inc. (BFLY) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- BFLY is the larger of the two at $2.41B, about 35.5x NNOX ($67.8M).
- BFLY has been more active in the news (14 items in the past 4 weeks vs 11 for NNOX).
- BFLY has more recent analyst coverage (8 ratings vs 4 for NNOX).
- Company
- Butterfly Network Inc.
- NANO-X IMAGING LTD
- Price
- -
- -
- Market cap
- $2.41B
- $67.8M
- 1M return
- +27.50%
- -
- 1Y return
- +468.55%
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 14
- 11
- Recent ratings
- 8
- 4
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest BFLY
- President & CEO Devivo Joseph gifted 250,000 shares, decreasing direct ownership by 3% to 7,353,700 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Robbins Larry sold $20,622,493 worth of shares (2,297,733 units at $8.98) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Phanstiel S. Louise bought $999,510 worth of shares (115,200 units at $8.68) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Butterfly Network Inc.
- Deputy General Counsel Caezza Nicholas sold $97,500 worth of shares (10,000 units at $9.75), decreasing direct ownership by 3% to 300,307 units (SEC Form 4)
- President & CEO Devivo Joseph sold $684,075 worth of shares (68,346 units at $10.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.89% to 7,603,700 units (SEC Form 4)
- Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 144 filed by Butterfly Network Inc.
Latest NNOX
- Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
- Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
- SEC Form 6-K filed by NANO-X IMAGING LTD
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Chief Executive Officer Meltzer Erez bought $9,726 worth of Ordinary Shares (9,443 units at $1.03) (SEC Form 4)
- SEC Form 6-K filed by NANO-X IMAGING LTD
- SEC Form 424B5 filed by NANO-X IMAGING LTD
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SEC Form 144 filed by NANO-X IMAGING LTD